Search

Displaying results 7871 - 7880 of 10000 in total
  1. Drug

    Capsicum annuum whole

    go.drugbank.com/drugs/DB14368
    Investigational

    Capsicum annuum whole is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.

  2. Drug

    Bisphosphocin Nu-3

    go.drugbank.com/drugs/DB16015
    Investigational

    Bisphosphocin Nu-3 is under investigation in clinical trial NCT02737722 (Topically Applied Bisphosphocin Nu-3 on Infected Diabetic Ulcers of Subjects With Type I or II Diabetes Mellitus).

  3. Drug

    Clonazoline

    go.drugbank.com/drugs/DB15881
    Experimental

    Clonazoline is

  4. Drug

    RGN6024

    go.drugbank.com/drugs/DB33059
    Experimental

    RGN6024, also known as RGN-6024 or RGNi6024, is a synthetic small-molecule tubulin destabilizer from Reglagene. … cells, and suppresses tumor growth in glioblastoma xenograft models.

  5. Drug

    Pemoline

    go.drugbank.com/drugs/DB01230
    ApprovedIllicitWithdrawn

    In 2005, the Food and Drug Administration (FDA) withdrew approval for pemoline. In March 2005, Abbott Laboratories (Cylert marketer) had discontinued the production of Cylert arguing economic reasons.

  6. Drug

    Methapyrilene

    go.drugbank.com/drugs/DB04819
    ApprovedWithdrawn

    Methapyrilene, formerly marketed in many drug products, was shown to be a potent carcinogen. Manufacturers voluntarily withdrew methapyriline drug products from the market in May and June 1979.

    Synonyms: N-(α-pyridyl)-N-(α-thenyl)-N',N'-dimethylethylenediamine, N,N-dimethyl-N'-pyrid-2-yl-N'-2-thenylethylenediamine
  7. Drug

    Tarazepide

    go.drugbank.com/drugs/DB06435
    Experimental

  8. Drug

    Labradimil

    go.drugbank.com/drugs/DB06549
    Investigational

  9. Drug

    Aplindore

    go.drugbank.com/drugs/DB06620
    Investigational

  10. Drug

    Lixivaptan

    go.drugbank.com/drugs/DB06666
    Investigational